Pharmaceutical

Attovia secures $105m to advance development of lead programmes

Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes.

May 11, 2024 - 04:00
Attovia secures $105m to advance development of lead programmes
Attovia Therapeutics has secured $105m in a Series B financing round to expedite the development of its lead programmes.
Read the original article

Tags:

Previous Article

Four ways the vaccine rush will define infectious disease trends for CROs in 2024

Next Article

Novo Nordisk enters deal to develop obesity therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Wall Street embraces health insurers after scoring Medicare Advantage payment win

STAT+: Wall Street embraces health insurers after scori...

Apr 7, 2023

STAT+: DeepMind touts AlphaFold’s new skills as protein-folding AI models face off

STAT+: DeepMind touts AlphaFold’s new skills as protein...

Nov 1, 2023

STAT+: Addiction treatment center founder indicted in sprawling fraud scheme

STAT+: Addiction treatment center founder indicted in s...

May 25, 2023